Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Vcreate Inc
Profile last edited on: 10/25/23      CAGE: 8NSH5      UEI: TDGANH2K4J93

Business Identifier: Using machine learning to understand and engineer human T-cell receptors (TCRs)
Year Founded
2020
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1546 San Antonio Avenue
Menlo Park, CA 94025
   (706) 594-5091
   contact@vcreate.io.
   www.vcreate.io.
Location: Single
Congr. District: 16
County: San Mateo

Public Profile

With T-cell receptors described as the next frontier for human health, Vcreate perseonnel are using machine learning to understand and engineer human T-cell receptors (TCRs) that can treat diseases impossible to treat before.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$512,581
Phase II Dollars
$0
Total Awarded
$512,581

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $256,581
Project Title: Computational algorithm to predict interacting MHC alleles from TCR sequences
2022 1 NSF $256,000
Project Title: High throughput and antigen specific T-cell receptor discovery through engineered macrophages

Key People / Management

  Binbin Chen -- CEO and Co-Founder

  Manjima Dhar -- Vice President of Cell Engineering

  Ethan Fast -- Co-founder and CTO

Company News

There are no news available.